These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8791489)

  • 41. Platelet-derived growth factor (PDGF)-signaling mediates radiation-induced apoptosis in human prostate cancer cells with loss of p53 function.
    Kim HE; Han SJ; Kasza T; Han R; Choi HS; Palmer KC; Kim HR
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):731-6. PubMed ID: 9336156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recruitment of p300/CBP in p53-dependent signal pathways.
    Avantaggiati ML; Ogryzko V; Gardner K; Giordano A; Levine AS; Kelly K
    Cell; 1997 Jun; 89(7):1175-84. PubMed ID: 9215639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation of p53-target genes and their functional analysis.
    Nakamura Y
    Cancer Sci; 2004 Jan; 95(1):7-11. PubMed ID: 14720320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An overview of research on p53 tumor suppressor gene].
    Yokozaki H; Tahara E
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2181-6. PubMed ID: 9422058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling.
    Goldstein M; Roos WP; Kaina B
    Toxicol Appl Pharmacol; 2008 May; 229(1):20-32. PubMed ID: 18289623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.
    Chen X; Ko LJ; Jayaraman L; Prives C
    Genes Dev; 1996 Oct; 10(19):2438-51. PubMed ID: 8843196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage.
    Minn AJ; Boise LH; Thompson CB
    Genes Dev; 1996 Oct; 10(20):2621-31. PubMed ID: 8895663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage.
    Camplejohn RS; Perry P; Hodgson SV; Turner G; Williams A; Upton C; MacGeoch C; Mohammed S; Barnes DM
    Br J Cancer; 1995 Sep; 72(3):654-62. PubMed ID: 7669577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A role for the tumour suppressor gene p53 in regulating neuronal apoptosis.
    Hughes PE; Alexi T; Schreiber SS
    Neuroreport; 1997 Oct; 8(15):v-xii. PubMed ID: 9351639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
    Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G
    Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.
    Yoshida K; Miki Y
    Cancer Sci; 2010 Apr; 101(4):831-5. PubMed ID: 20132225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation.
    Hickman ES; Picksley SM; Vousden KH
    Oncogene; 1994 Aug; 9(8):2177-81. PubMed ID: 8036003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A role revealed for p53.
    Nat Struct Biol; 1994 Aug; 1(8):487-8. PubMed ID: 7664068
    [No Abstract]   [Full Text] [Related]  

  • 58. p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
    Waldman T; Kinzler KW; Vogelstein B
    Cancer Res; 1995 Nov; 55(22):5187-90. PubMed ID: 7585571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death.
    Hardenbergh PH; Hahnfeldt P; Hlatky L; Takemoto C; Shimamura A; McGill G; Fung CY; Bodis S; Fisher DE
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):601-5. PubMed ID: 10078645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.